Interaction databaseSupplement × PrescriptionReviewed May 2026

Oxybutynin and Potassium, a caution.

Solid oral potassium chloride supplements can injure the upper gastrointestinal mucosa, and controlled endoscopy studies found more frequent or worse lesions when gastric motility was slowed with an anticholinergic. Oxybutynin is an antimuscarinic that can cause constipation and is contraindicated in gastric retention. The concern is greatest with wax-matrix or other solid potassium chloride products, high potassium doses, dehydration, or existing swallowing or GI motility problems.

One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.

Sourcing standards·Evidence tiers

From the interaction database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.

At a glance

Substances
Oxybutynin and Potassium
Pair type
Caution
Evidence (highest tier)
Moderate
Source citations
4 sources
Stack Score effect
−5 to your Stack Score (per scored caution row).
Scope
Supplement × Prescription
Last verified
May 30, 2026

Caution · Moderate evidence

Caution

What is happening. Solid oral potassium chloride supplements can injure the upper gastrointestinal mucosa, and controlled endoscopy studies found more frequent or worse lesions when gastric motility was slowed with an anticholinergic. Oxybutynin is an antimuscarinic that can cause constipation and is contraindicated in gastric retention. The concern is greatest with wax-matrix or other solid potassium chloride products, high potassium doses, dehydration, or existing swallowing or GI motility problems.

Mechanism. Oxybutynin blocks muscarinic signaling and can slow gastrointestinal motility. Prolonged mucosal contact with concentrated potassium chloride from solid formulations can cause erosions or ulceration; anticholinergic-induced delayed emptying increases that contact time.

Recommendation. Do not start solid potassium tablets or capsules while taking oxybutynin unless a clinician has recommended them and checked that they are necessary. If potassium is needed, ask whether liquid, powder-in-water, dietary potassium, or a monitored alternative is safer. Seek care for severe abdominal pain, black stools, vomiting blood, or painful swallowing.

Sources (4)
  1. Dwyer J, Tafuri SM, LaGrange CA. Oxybutynin. StatPearls. 2026. PMID 29763161
  2. McMahon FG, Ryan JR, Akdamar K, Ertan A. Upper gastrointestinal lesions after potassium chloride supplements: a controlled clinical trial. Lancet. 1982;2(8307):1059-1061. PMID 6127542
  3. McMahon FG, Ryan JR, Akdamar K, Ertan A. Effect of potassium chloride supplements on upper gastrointestinal mucosa. Clin Pharmacol Ther. 1984;35(6):852-855. PMID 6734038
  4. Sinar DR, Bozymski EM, Blackshear JL. Effects of oral potassium supplements on upper gastrointestinal mucosa: multicenter clinical comparison of three formulations and placebo. Clin Ther. 1986;8(2):157-163. PMID 3698061

Stack Score

How this pair moves the number.

Effect on the composite score

If both Oxybutynin and Potassium are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).

The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.

Check your full routine

One pair was the worked example. NutriStack runs every pair in your stack at once.

Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.